SCHEMBL2907592

SCHEMBL2907592

O=C(NC1CCCCC1)C(C1CCCCC1)C1(C(O)c2cccc(Cl)c2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
EPHX2 P34913 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
EPHX1 P07099 1/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CNR2 P34972 3/20 0.40
METAP2 P50579 2/20 0.40
CNR1 P21554 2/20 0.40
METAP1 P53582 1/20 0.40
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 1/20 0.39
KCNH2 Q12809 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915021 0.89 KCNH2 (0.44) NPC1RAB9ALMNAEPHX1TSHR
SCHEMBL2913040 0.89 TSHR (0.44) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL2912425 0.86 TSHR (0.40) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL2909615 0.84 C3AR1 (0.43) TSHRCYP3A4CYP2D6CYP2C9SMN1; SMN2
SCHEMBL2906901 0.84 CNR1 (0.40) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL4035068 0.82 NPC1 (0.46) NPC1RAB9AEPHX2MEN1KMT2A
SCHEMBL2915685 0.81 NPC1 (0.39) NPC1RAB9AEPHX2MEN1KMT2A
SCHEMBL2912405 0.81 ALDH1A1 (0.40) NPC1RAB9ALMNAEPHX1TSHR
SCHEMBL2915028 0.79 KMT2A (0.43) NPC1RAB9AEPHX2MEN1KMT2A
SCHEMBL2912657 0.79 EPHX2 (0.51) NPC1RAB9AEPHX2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed